Vaccibody As Probability of Future Stock Price Finishing Under 2.34
| VACCDelisted Stock | USD 2.23 0.04 1.83% |
Vaccibody |
Vaccibody Target Price Odds to finish below 2.34
The tendency of Vaccibody Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 2.34 after 90 days |
| 2.23 | 90 days | 2.34 | about 45.74 |
Based on a normal probability distribution, the odds of Vaccibody to stay under $ 2.34 after 90 days from now is about 45.74 (This Vaccibody As probability density function shows the probability of Vaccibody Stock to fall within a particular range of prices over 90 days) . Probability of Vaccibody As price to stay between its current price of $ 2.23 and $ 2.34 at the end of the 90-day period is about 34.5 .
Given the investment horizon of 90 days Vaccibody has a beta of 0.91. This entails Vaccibody As market returns are highly-sensitive to returns on the market. As the market goes up or down, Vaccibody is expected to follow. Additionally Vaccibody As has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Vaccibody Price Density |
| Price |
Predictive Modules for Vaccibody
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vaccibody As. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaccibody's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaccibody Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vaccibody is not an exception. The market had few large corrections towards the Vaccibody's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vaccibody As, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vaccibody within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 0.91 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.1 |
Vaccibody Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vaccibody for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vaccibody As can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vaccibody As is not yet fully synchronised with the market data | |
| Vaccibody As has a very high chance of going through financial distress in the upcoming years | |
| Vaccibody As currently holds about 192.33 M in cash with (14.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Vaccibody Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vaccibody Stock often depends not only on the future outlook of the current and potential Vaccibody's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaccibody's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.2 M | |
| Cash And Short Term Investments | 194.4 M |
Vaccibody Technical Analysis
Vaccibody's future price can be derived by breaking down and analyzing its technical indicators over time. Vaccibody Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vaccibody As. In general, you should focus on analyzing Vaccibody Stock price patterns and their correlations with different microeconomic environments and drivers.
Vaccibody Predictive Forecast Models
Vaccibody's time-series forecasting models is one of many Vaccibody's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vaccibody's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vaccibody As
Checking the ongoing alerts about Vaccibody for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vaccibody As help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vaccibody As is not yet fully synchronised with the market data | |
| Vaccibody As has a very high chance of going through financial distress in the upcoming years | |
| Vaccibody As currently holds about 192.33 M in cash with (14.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Vaccibody Stock
If you are still planning to invest in Vaccibody As check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccibody's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |